Advertisement
News
Subscribe to MDT Magazine News

New Topical Research Reports by iData Research Published by MarketPublishers.com

December 16, 2010 4:32 am | by Bio-Medicine.Org | Comments

LONDON, Dec. 16, 2010 /- Market Publishers Ltd informs that new in-demand market research reports by iData Research have been added to its catalogue. Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 . In 2010, the Asia Pacific markets for...

TOPICS:

Guardian 24/7 Offers Remote High-Touch Health Care via Glowpoint Video Managed Services

December 16, 2010 4:32 am | by Bio-Medicine.Org | Comments

HILLSIDE, N.J., Dec. 16, 2010 /- Glowpoint, Inc. (OTC Bulletin Board: GLOW ), a provider of cloud-based managed services for telepresence , video conferencing and collaboration , today announced that Guardian 24/7, a health care provider for high-profile executives, has selected...

TOPICS:

Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly

December 16, 2010 2:31 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the...

TOPICS:
Advertisement

Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer

December 15, 2010 11:32 pm | by Bio-Medicine.Org | Comments

SAN FRANCISCO and ILLKIRCH, France, Dec. 16, 2010 /- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a...

TOPICS:

Watson and Richter Announce Exclusive License Agreement for Esmyaâ„¢

December 15, 2010 11:32 pm | by Bio-Medicine.Org | Comments

MORRISTOWN, N.J., and BUDAPEST, HUNGARY, Dec. 16, 2010 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) ("Watson") and Gedeon Richter Plc ("Richter") today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A.,...

TOPICS:

Okla. set to execute inmate with substitute drug

December 15, 2010 10:45 pm | by SEAN MURPHY - Associated Press - Associated Press | Comments

A man on Oklahoma's death row for the 2001 slaying of his cellmate is believed to be the first U.S. inmate set to be executed using a sedative commonly used to euthanize animals.John David Duty is set to die at 6 p.m. Thursday at the Oklahoma State Penitentiary in McAlester. A federal appeals...

Bioethics Commission calls for enhanced federal oversight in new field of synthetic biology

December 15, 2010 8:32 pm | by EurekAlert | Comments

(Burness Communications) The Presidential Commission for the Study of Bioethical Issues today released its first report -- a wide-ranging review of the emerging field of synthetic biology -- issuing 18 recommendations including a call for coordinated federal oversight of scientists...

TOPICS:

Cell-Seeded Sutures to Repair the Heart

December 15, 2010 7:32 pm | by Massachusetts Institute of Technology | Comments

Polymer threads coated with stem cells might one day heal damaged cardiac muscle.

Advertisement

Big possibilities in brain-computer interface

December 15, 2010 4:34 pm | by Arizona State University | Comments

An ASU researcher talks about progress in brain-computer interface technology being developed to help people incapacitated by injury or neurological disorders.read more

TOPICS:

Medical device maker Orthofix cuts restructures(3)

December 15, 2010 3:45 pm | by The Associated Press | Comments

Orthofix International N.V., a medical device company, announced Wednesday that it settled a patent lawsuit and separately plans to save up to $7 million per year with a restructuring that will include cutting an unspecified number of jobs.The actions will cut into Orthofix's fourth-quarter...

Spine surgery device makers settles patent dispute

December 15, 2010 2:48 pm | by The Associated Press | Comments

Medical device maker NuVasive Inc., which develops products used in spine surgery, said Wednesday that it settled a patent dispute with Orthofix International N.V. and The Musculoskeletal Transplant Foundation for undisclosed terms.Device maker Orthofix — which also said Wednesday that it has...

Kindred expects 4Q profit near top of guidance

December 15, 2010 2:47 pm | by The Associated Press | Comments

Health care services company Kindred Healthcare Inc. said Wednesday that it expects fourth-quarter profit to reach the upper end of its prior forecast for profit of 38 cents to 43 cents per share.Analysts polled by Thomson Reuters on average expect it to report profit of about 40 cents per...

Medical device maker Orthofix cuts restructures(2)

December 15, 2010 2:46 pm | Comments

Orthofix International N.V., a medical device company, announced Wednesday that it settled a patent lawsuit and separately plans to save up to $7 million per year with a restructuring that will include cutting an unspecified number of jobs.The actions will cut into Orthofix's fourth-quarter...

SABCS 2010 Interview with Amelie G. Ramirez, Dr.P.H.

December 15, 2010 1:33 pm | by AACR | Comments

Dr. Ramirez discusses the importance of genetic testing for breast cancer among Latinas, statewide and national communications programs, challenges facing the Hispanic community in reference to cancer, and how to address some of these concerns.

TOPICS:

New research finds delaying surgical procedures increases infection risk and health care costs

December 15, 2010 1:31 pm | by EurekAlert | Comments

(Weber Shandwick Worldwide) Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading